Sell-side Consensus: Altria

Share on facebook
Share on twitter
Share on email
Share on whatsapp
Share on linkedin

Below is a summary of Altria price targets of major financial services firms which updated or reiterated their ratings in the last 12 months. Average sell-side price target for Altria was fairly stable around $50 for a long-time. However, Q3 3023 release (October 26, 2023) led to a series of price target cuts. Altria reported -2.5% revenue decline and narrowed / lowered the FY23 EPS guidance on that occasion. Recall: “Altria: Q3 2023 Results“. Altria’s “not worse-than-expected” Q4 2023 & FY23 results (Feburary 1, 2024) triggered only a short-lived relief rally and failed to put an end to the price target cuts. Recall: “Altria: Q4 2023 Results“.

Currently, there is no analyst left with Altria price target above $50. Sell-side is also increasingly realizing the transformational challenges faced by Altria (the “bear case”). The average sell-side target for Altria is now down to $43.1. Based on the last closing price of $42.1, Altria is fairly valued (- the only major tobacco companies in which sell-side sees less than 5% upside).

See our “Point of Caution” as you interpret the table below.

DateAnalystFromToRating
Apr 9, 2024UBS$36.1$36.5Sell
Mar 25, 2024Stifel$50$50Buy
Mar 14, 2024Goldman Sachs$46$47Buy
Feb 19, 2024Jefferies$49$47Buy
Feb 4, 2024Bernstein$47$43Buy
Jan 30, 2024 Morgan Stanley$44$42Neutral*
Oct 26, 2023TD Cowen$47$42Neutral*
Oct 26, 2023Citigroup$45$42Neutral
Oct 26, 2023CFRA$45 $35Sell
Oct 10, 2023Bank of America$49$47Neutral*
Consensus$43.12S,4N, 4B
* Market-perform/Equal-weight

Point of Caution

Sell-side work has a level of influence on investors despite the fact that

– the accuracy and knowledge attributed to the analysts tend to be over-stated

– analyst targets are frequently criticized to be reactive, rather than predictive (i.e. following the actual price progression rather than foreseeing it)

– there are serious studies claiming that companies with the most ambitious analyst targets consistently generate subpar returns

– many suspect analysts are influenced by inherent conflicts of interests and business relationships.

Nevertheless, sell-side is an integral part of the business-investing ecosystem and we cover their work for the sake of completeness. Moreover, we need to underline that following decades-long stability in operating and competitive environment, the Tobacco Industry is experiencing a perfect storm of multi-dimensional and concurrent transformation (driven by the replacement of traditional cigarettes by RRP/NGPs) – a phenomenon that makes it more difficult than ever for the sell-side analysts to grasp the business/market dynamics and establish fairly accurate financial models.

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address